首页> 外国专利> Sphingolipids in treatment and prevention of steatosis and of steatosis or of hepatotoxicity and its sequelae

Sphingolipids in treatment and prevention of steatosis and of steatosis or of hepatotoxicity and its sequelae

机译:鞘脂治疗和预防脂肪变性和脂肪变性或肝毒性及其后遗症

摘要

The present invention relates to the use of sphingolipids for the preparation of a food item, a food supplement and/or a medicament for the prevention and/or treatment of elevated blood levels of cholesterol and triglycerides related to steatosis and hepatotoxic effects of medicaments and viral infections. In particular, the invention relates to the use of a sphingolipid such as phytosphingosine, sphingosine, sphinganine, ceramide, glycosylceramide and/or sphingomyelin, or a precursor or a derivative of a sphingolipid, or a pharmaceutically acceptable salt thereof, for the prevention and/or treatment of hepatotoxic effects such as hepatic steatosis, fibrosis and/or cirrhosis.; embedded image
机译:本发明涉及鞘脂在制备食品,食品补充剂和/或药物中的用途,所述食品,食品补充剂和/或药物用于预防和/或治疗与脂肪变性和药物和病毒性肝毒性有关的胆固醇和甘油三酸酯的血药浓度升高感染。特别地,本发明涉及鞘脂如植物鞘氨醇,鞘氨醇,鞘氨醇,神经酰胺,糖基神经酰胺和/或鞘磷脂的用途,或鞘脂的前体或衍生物,或其药学上可接受的盐的用途。或治疗肝毒性作用,例如肝脂肪变性,纤维化和/或肝硬化。 “嵌入式图像”

著录项

  • 公开/公告号US7906488B2

    专利类型

  • 公开/公告日2011-03-15

    原文格式PDF

  • 申请/专利权人 WILLEM FERDINAND NIEUWENHUIZEN;

    申请/专利号US20050791876

  • 发明设计人 WILLEM FERDINAND NIEUWENHUIZEN;

    申请日2005-11-25

  • 分类号A61K31/70;A61K31/66;A61K31/22;

  • 国家 US

  • 入库时间 2022-08-21 18:09:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号